Article Details
Retrieved on: 2021-05-11 15:56:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
The findings add new evidence to the case for the PD-1–targeting monoclonal antibodies in the first-line setting for metastatic NSCLC. The report was ...
Article found on: www.cancernetwork.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here